Ameritas Investment Partners’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $55.2K | Buy |
+22,986
| New | +$44.8K | ﹤0.01% | 2208 |
|
|
2025
Q2 | – | Sell |
-8,867
| Closed | -$4.09K | – | 3280 |
|
|
2025
Q1 | $4.09K | Hold |
8,867
| – | – | ﹤0.01% | 3012 |
|
|
2024
Q4 | $6.55K | Hold |
8,867
| – | – | ﹤0.01% | 2993 |
|
|
2024
Q3 | $13.9K | Hold |
8,867
| – | – | ﹤0.01% | 2812 |
|
|
2024
Q2 | $14.9K | Hold |
8,867
| – | – | ﹤0.01% | 2746 |
|
|
2024
Q1 | $21.3K | Buy |
8,867
+3,500
| +65% | +$7.52K | ﹤0.01% | 2541 |
|
|
2023
Q4 | $8.21K | Hold |
5,367
| – | – | ﹤0.01% | 2894 |
|
|
2023
Q3 | $5.85K | Hold |
5,367
| – | – | ﹤0.01% | 2964 |
|
|
2023
Q2 | $12.3K | Hold |
5,367
| – | – | ﹤0.01% | 2829 |
|
|
2023
Q1 | $13K | Hold |
5,367
| – | – | ﹤0.01% | 2624 |
|
|
2022
Q4 | $12K | Hold |
5,367
| – | – | ﹤0.01% | 2763 |
|
|
2022
Q3 | $12K | Hold |
5,367
| – | – | ﹤0.01% | 2749 |
|
|
2022
Q2 | $9K | Hold |
5,367
| – | – | ﹤0.01% | 2860 |
|
|
2022
Q1 | $11K | Hold |
5,367
| – | – | ﹤0.01% | 2763 |
|
|
2021
Q4 | $21K | Hold |
5,367
| – | – | ﹤0.01% | 2624 |
|
|
2021
Q3 | $26K | Hold |
5,367
| – | – | ﹤0.01% | 2560 |
|
|
2021
Q2 | $25K | Buy |
5,367
+1,585
| +42% | +$7.63K | ﹤0.01% | 2622 |
|
|
2021
Q1 | $22K | Hold |
3,782
| – | – | ﹤0.01% | 2524 |
|
|
2020
Q4 | $13K | Hold |
3,782
| – | – | ﹤0.01% | 2682 |
|
|
2020
Q3 | $5K | Hold |
3,782
| – | – | ﹤0.01% | 2976 |
|
|
2020
Q2 | $8K | Hold |
3,782
| – | – | ﹤0.01% | 2821 |
|
|
2020
Q1 | $7K | Hold |
3,782
| – | – | ﹤0.01% | 2686 |
|
|
2019
Q4 | $16K | Hold |
3,782
| – | – | ﹤0.01% | 2519 |
|
|
2019
Q3 | $11K | Hold |
3,782
| – | – | ﹤0.01% | 2702 |
|
|
2019
Q2 | $24K | Hold |
3,782
| – | – | ﹤0.01% | 2345 |
|
|
2019
Q1 | $21K | Hold |
3,782
| – | – | ﹤0.01% | 2352 |
|
|
2018
Q4 | $25K | Hold |
3,782
| – | – | ﹤0.01% | 2208 |
|
|
2018
Q3 | $40K | Hold |
3,782
| – | – | ﹤0.01% | 2114 |
|
|
2018
Q2 | $45K | Hold |
3,782
| – | – | ﹤0.01% | 2053 |
|
|
2018
Q1 | $32K | Hold |
3,782
| – | – | ﹤0.01% | 2179 |
|
|
2017
Q4 | $37K | Hold |
3,782
| – | – | ﹤0.01% | 2092 |
|
|
2017
Q3 | $57K | Hold |
3,782
| – | – | ﹤0.01% | 1808 |
|
|
2017
Q2 | $62K | Buy |
3,782
+549
| +17% | +$8.5K | ﹤0.01% | 1761 |
|
|
2017
Q1 | $46K | Buy |
+3,233
| New | +$48K | ﹤0.01% | 1904 |
|
|
2015
Q2 | – | Sell |
-2,553
| Closed | -$17K | – | 1196 |
|
|
2015
Q1 | $17K | Hold |
2,553
| – | – | ﹤0.01% | 1143 |
|
|
2014
Q4 | $16K | Hold |
2,553
| – | – | ﹤0.01% | 1126 |
|
|
2014
Q3 | $25K | Hold |
2,553
| – | – | ﹤0.01% | 1048 |
|
|
2014
Q2 | $29K | Hold |
2,553
| – | – | ﹤0.01% | 1082 |
|
|
2014
Q1 | $31K | Hold |
2,553
| – | – | ﹤0.01% | 1053 |
|
|
2013
Q4 | $32K | Hold |
2,553
| – | – | ﹤0.01% | 1050 |
|
|
2013
Q3 | $42K | Buy |
+2,553
| New | +$42.8K | ﹤0.01% | 990 |
|
Other funds holding LXRX
AG
SL
Ameritas Investment Partners's LXRX Position: Q2 2026 in Review
Ameritas Investment Partners opened a new position in Lexicon Pharmaceuticals (LXRX) in Q2 2026: 22,986 shares worth $55.2K. The stake represents ﹤0.01% of the portfolio and ranks #2208 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in LXRX as recently as Q1 2025.
Ameritas Investment Partners first reported a position in LXRX in Q3 2013 and has held it in 41 quarters since. The position peaked at $62K in Q2 2017. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.
- Ameritas Investment Partners held 22,986 shares of Lexicon Pharmaceuticals worth $55.2K as of Q2 2026.
- Lexicon Pharmaceuticals was a new Ameritas Investment Partners position in Q2 2026.
- Lexicon Pharmaceuticals made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2208 holding.
- Ameritas Investment Partners first reported a position in Lexicon Pharmaceuticals in Q3 2013 and has held it in 41 quarters since.
- Ameritas Investment Partners's Lexicon Pharmaceuticals position peaked at $62K in Q2 2017.
- 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.